NEOCUTIS technology platform relies on the use of cultured fetal skin cells obtained from a cell bank for treating various skin conditions. The dedicated cell bank was originally established for wound healing and burn treatments using a single biopsy of donated fetal skin following a one-time medical termination. The cultured cells can be used to produce skin constructs for wound healing or can be incorporated as cell lysate in a topical carrier for use in dermatology and skin care. The cultured cells originating from this cell bank are used in research and product development in the following areas: acute and chronic wound healing, eczema and psoriasis and vulvodynia.